Huchems (069260) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Huchems KRW 26,542, price KRW 16,200, upside +63.8%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Huchems for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 13,685 KRW – 23,451 KRW · fair‑value band 19,906 KRW – 33,177 KRW · the 16,200 KRW price screens below the 26,542 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Huchems in your weekly email
Every Wednesday you see whether Huchems is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
TKG Huchems Co., Ltd. manufactures and sells fine chemical products in South Korea and internationally. It offers nitric acid, ammonium nitrate, mononitrobenzene, dinitrotoluene, and ammonia products. The company is also involved in the clean development mechanism business; and provision of urea solutions.
Show more
TKG Huchems Co., Ltd. manufactures and sells fine chemical products in South Korea and internationally. It offers nitric acid, ammonium nitrate, mononitrobenzene, dinitrotoluene, and ammonia products. The company is also involved in the clean development mechanism business; and provision of urea solutions. The company was formerly known as Huchems Fine Chemical Corporation and changed its name to TKG Huchems Co.,Ltd. in March 2022. TKG Huchems Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
Stock analysis
Huchems (069260) currently trades at 16,200 KRW, while our model-based Fair Value estimate is 26,542 KRW, implying the stock looks roughly 39.0% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 32,193 KRW per share, and 19 of the 23 models we run sit above the 16,200 KRW price.
Bear case: the Earnings-Based group reads lowest at 13,475 KRW, and 4 of the 23 models stay below the price. Evidence for this calculation is medium.
Scenario range: 19,906 KRW (bear) to 33,177 KRW (bull), the price of 16,200 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Huchems reported revenue of 1.1T KRW in FY2025 versus 861B KRW in FY2021, a compound +7.0%/yr. Reported net income was 59.9B KRW in FY2025, compounding −5.7%/yr from FY2021.
Key figures
Market cap 622B KRW (≈ $457M) · P/S ratio 0.51 · Dividend yield 6.2% · Net margin 5.3% · Return on equity 6.6% · Return on assets (EBIT) 9.2% · Operating margin 5.2% · Revenue (TTM) 1.2T KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 20% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −27% fair-value upside, at 64%, 069260 screens cheaper than that median.
Fair Value models
Bear 19,906 KRWFair Value 26,542 KRWBull 33,177 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−5.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.7%
Start year 2020 (pandemic). Over 10 years: +6.5% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+3.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.2%
Dividend (yield on the price)6.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 6%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−13.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −15.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 352 stocks
Beats the industry median on 9/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score61 · Top 25%
Fair Value upside+64% · Top 25%
Profitability
Return on equity (TTM)7% · Above median
Return on assets4% · Above median
Net margin (TTM)5% · Above median
Operating margin (TTM)5% · Below median
Growth and dividend
Revenue growth10% · Above median
Dividend yield (TTM)6.2% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Huchems Fair Value". https://www.fairvalue-calculator.com/stock/069260
Frequently asked questions
Is Huchems (069260) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 26,542 KRW versus a price of 16,200 KRW, about +64% upside (undervalued).
What is the fair value of 069260?
Our model-based fair value for Huchems is 26,542 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 16,200 KRW.
What is the quality score of 069260?
Huchems has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Huchems (069260)?
Our model-based price target is the fair value of 26,542 KRW (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 19,906 KRW, optimistic scenario 33,177 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Huchems stock forecast for 2026?
Our models put fair value at 26,542 KRW, about +64% upside versus a price of 16,200 KRW (undervalued). Cautious scenario 19,906 KRW, optimistic scenario 33,177 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Huchems (069260)?
Huchems reported trailing-twelve-month revenue of about 1.2T KRW (latest available figure, as of Sep 24, 2026).
Does Huchems pay a dividend?
Huchems currently shows a dividend yield of about 6.17% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Huchems (069260)?
For today's price to be fair in a discounted-cash-flow model, Huchems would have to grow free cash flow by -13.2 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 069260 use?
Our models discount Huchems at 10.2 %: a base by market capitalisation (small), damped by beta 0.26, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Huchems that is -13.2 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has Huchems (069260) delivered so far?
Over the past 5 years revenue at Huchems grew +13.7 % a year. The price currently implies -13.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Huchems (069260) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Huchems (-13.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Huchems (069260)?
The free-cash-flow yield on the price is 14.55 %: that much free cash flow Huchems produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Huchems (069260)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Huchems it is 26,542 KRW per share (as of Sep 24, 2026), against a price of 16,200 KRW. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Huchems stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 069260 trades below its calculated fair value: price 16,200 KRW, fair value 26,542 KRW, a gap of about +64% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 069260?
No. The price is what the market pays today (16,200 KRW); the fair value is what the company's own numbers justify (26,542 KRW). For Huchems the two are 10,342 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Huchems worth?
The market values Huchems at about 622B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 16,200 KRW; our models calculate a fair value of 26,542 KRW per share.
What do the bullish and bearish scenarios say about 069260?
Our models span a range for Huchems: cautious scenario 19,906 KRW, base 26,542 KRW, optimistic 33,177 KRW per share (as of Sep 24, 2026, price 16,200 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Huchems (069260)?
Balance-sheet figures for Huchems (as of Sep 24, 2026): return on equity 6.6%, debt of 0.01 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is 069260 from its 52-week high?
Huchems trades at 16,200 KRW, about 20% below its 52-week high of 20,176 KRW and 11% above the low of 14,650 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 26,542 KRW is for.
Which stocks are comparable to Huchems?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Ningxia Baofeng Energy Group, Dow Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Huchems stock attractive at the current price?
The data as of Sep 24, 2026: price 16,200 KRW, calculated fair value 26,542 KRW (+64%), Quality Score 61/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 069260 calculated?
We run Huchems through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 26,542 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Huchems currently trades 64 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Huchems (069260)?
The closing price on Sep 23, 2026 was 16,200 KRW. Our model-based fair value is 26,542 KRW, about +64% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Huchems right now?
The price is below even our cautious bear case (19,906 KRW). The market is more pessimistic than our downside scenario. Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Huchems
How large is the market capitalisation of Huchems (069260)?
The market capitalisation of Huchems is 622B KRW (≈ $457M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Huchems (069260)?
The price-to-sales ratio of Huchems is 0.51 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Huchems (069260)?
The dividend yield of Huchems is 6.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Huchems (069260)?
The net margin of Huchems is 5.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Huchems (069260)?
The return on equity (ROE) of Huchems is 6.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Huchems (069260)?
On an EBIT basis the return on assets of Huchems is 9.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Huchems (069260)?
The operating margin of Huchems is 5.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Huchems (069260)?
Revenue at Huchems is growing +9.5% versus a year earlier (3y avg −3.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Huchems (069260)?
Earnings per share at Huchems are growing −3.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Huchems (069260) carry?
The net debt of Huchems is 27.5B KRW (fiscal year 2024, ≈ 0.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Huchems in the live analysis
One click puts Huchems on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
